Prognostic value of systolic short-term blood pressure variability in systolic heart failure. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Berry, Matthieu; Lairez, Olivier; Fourcade, Joelle; Roncalli, Jérôme; Carrié, Didier; Pathak, Atul; Chamontin, Bernard; Galinier, Michel
• Is Part Of: Clinical hypertension. Volume 22:Issue 1(2016)
• Page Start: 1
• Page End: 6
• Publication Date: 2016-12
• Subjects: Heart failure -- Blood pressure variability -- Prognosis; Hypertension -- Periodicals; 616.132
• DOI: 10.1186/s40885-016-0051-z
• Languages: English
• ISSNs: 2056-5909

Abstract

Abstract Background Traditional cardiovascular risk factors in the general population are usually correlated to a better prognosis in patients with chronic heart failure (HF). Most of the studies show that blood pressure variability (BPV) has noxious effect on general population but data are missing for patients with systolic HF. The aim of this study was to assess the prognostic impact of short-term blood pressure variability (BPV) in systolic HF. Methods and results We retrospectively studied 288 patients (60 ± 12 years-old; 79 % male) referred to our tertiary center of HF for the management of their systolic HF (left ventricular ejection fraction was 28 ± 9 %). All patients underwent ambulatory blood pressure monitoring (systolic BP: 110 ± 15; diastolic BP: 68 ± 10 and pulse pressure: 42 ± 11 mmHg) and the prognostic impact of BPV was collected with a mean follow-up of 4.4 ± 3.1 years. Twenty-five (9 %) patients were missing for follow-up. Among the others patients, 70 (27 %) cardiovascular events (cardiac deaths: 24 %; heart transplantation: 2 %) were recorded. By multivariate analysis BPV daytime (OR = 0.963, p = 0.033) and severe NYHA class (OR = 5.2, p < 0.0001) were found as independent predictors of cardiac event. Patients with a systolic daytime BPV under a cut-off value of 19 mmHg had the poorest prognosis with an OR for cumulative events of 1.65 (IC95 % 1.1–2.7;p < 0.04). Conclusion BPV is simple tool and a predictor of cardiac events in patients with systolic HF.